Izlaganje sa skupa

Meloxicam - the balance of efficacy and safety

Jadranka Morović-Vergles ; Zavod za kliničku imunologiju i reumatologiju, Klinika za unutarnje bolesti, Klinička bolnica “Dubrava”, Zagreb, Hrvatska

Sažetak

NSAIDs remain the principal pharmacological agents used for symptom relief in patients with rheumatic disease. They represent the largest single group of drugs used worldwide. Given the large number of available NSAIDs, it is unsurprising that some differences exist among them with regard to mechanism of action, pharmacokinetics, and tolerability. How these differences affect the overall risks and benefits of treatment continues to be examined in clinical trials. Meloxicam is COX-2 selective NSAID with favourable gastrointestinal and thromboembolic safety profile.

Ključne riječi

NSAID; meloxicam; safety profile

Hrčak ID:

125255

URI

https://hrcak.srce.hr/125255

Datum izdavanja:

17.10.2008.

Podaci na drugim jezicima: hrvatski

Posjeta: 1.144 *